Article Information
History
- November 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hui-Lee Wong1,
- Ellen Tworkoski2,
- Cindy Ke Zhou1,
- Mao Hu2,
- Deborah Thompson1,
- Bradley Lufkin2,
- Rose Do1,
- Laurie Feinberg2,
- Yoganand Chillarige2,
- Rositsa Dimova1,
- Patricia Lloyd1,
- Thomas MaCurdy2,3,
- Richard A. Forshee1,
- Jeffrey Kelman4,
- Azadeh Shoaibi1 and
- Steven A. Anderson1,*
- 1US Food and Drug Administration, Silver Spring, MD
- 2Acumen LLC, Burlingame, CA
- 3Department of Economics, Stanford University, Stanford, CA, USA
- 4Centers for Medicare & Medicaid Services, Washington, DC
- ↵*Corresponding Author:
Steven A. Anderson, PhD, email: steven.anderson{at}fda.hhs.gov (SA)
Posted November 05, 2022.
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older
